Skip to main content
Erschienen in: Abdominal Radiology 12/2018

30.05.2018 | Pictorial essay

Peritumoral tissue on preoperative imaging reveals microvascular invasion in hepatocellular carcinoma: a systematic review and meta-analysis

verfasst von: Hang-Tong Hu, Shun-Li Shen, Zhu Wang, Quan-Yuan Shan, Xiao-Wen Huang, Qiao Zheng, Xiao-Yan Xie, Ming-De Lu, Wei Wang, Ming Kuang

Erschienen in: Abdominal Radiology | Ausgabe 12/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

Histologic microvascular invasion (MVI) substantially worsens the prognosis of patients with hepatocellular carcinoma, and can only be diagnosed postoperatively. Preoperative assessment of MVI by imaging has been focused on tumor-related features, while peritumoral imaging features have been indicated elsewhere to be more accurate. The aim of the present study is to evaluate the association between peritumoral imaging features and MVI.

Methods

Literature search was performed using the PubMed, Embase, and Cochrane Library databases. Summary results of the association between peritumoral imaging features and MVI were presented as the odds ratio (OR) and the 95% confidence interval. Meta-regression and subgroup analyses were performed when heterogeneity was detected. Diagnostic accuracy analysis was also conducted for identified features.

Results

Ten studies were included in the analysis. Moderate and low heterogeneities were found among the seven studies on peritumoral enhancement and four studies on peritumoral hypointensity on HBP, respectively. Summary results revealed a significant association between MVI and peritumoral enhancement (OR 4.04 [2.23, 7.32], p < 0.05), and peritumoral hypointensity on HBP (OR 10.62 [5.31, 21.26], p < 0.05). Diagnostic accuracy analysis revealed high specificity (0.90-0.94) but low sensitivity (0.29–0.40) for both features to assess MVI.

Conclusion

The two peritumoral imaging features are significantly associated with MVI. The two features highly suggest MVI only when present with a high false negative rate. Promotion of their diagnostic efficiency can be a worthwhile task for future research.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
19.
Zurück zum Zitat Tsujita E, Yamashita Y, Takeishi K, et al. (2013) The clinicopathological impact of gross classification on solitary small hepatocellular carcinoma. Hepatogastroenterology 60(127):1726–1730PubMed Tsujita E, Yamashita Y, Takeishi K, et al. (2013) The clinicopathological impact of gross classification on solitary small hepatocellular carcinoma. Hepatogastroenterology 60(127):1726–1730PubMed
21.
Zurück zum Zitat Renzulli M, Buonfiglioli F, Brocchi S, et al. (2016) Imaging features of microvascular invasion in hepatocellular carcinoma developed in HCV-related cirrhosis after direct-acting antiviral therapy. Hepatology 64(1):223A–224A Renzulli M, Buonfiglioli F, Brocchi S, et al. (2016) Imaging features of microvascular invasion in hepatocellular carcinoma developed in HCV-related cirrhosis after direct-acting antiviral therapy. Hepatology 64(1):223A–224A
23.
Zurück zum Zitat Kobayashi T, Aikata H, Daijo K, et al. (2016) Comparison of 18F-FDG PET-CT and Gd-EOB-DTPA-enhanced MRI for prediction of microvascular invasion and outcome after curative resection for early-stage hepatocellular carcinoma. Hepatology 64(1):218A Kobayashi T, Aikata H, Daijo K, et al. (2016) Comparison of 18F-FDG PET-CT and Gd-EOB-DTPA-enhanced MRI for prediction of microvascular invasion and outcome after curative resection for early-stage hepatocellular carcinoma. Hepatology 64(1):218A
24.
Zurück zum Zitat Robinson E, Chandarana H, Droxhinin L, et al. (2009) MRI features of HCC do not predict microvascular invasion in liver transplant for hepatocellular carcinoma. Liver Transpl 15:S111CrossRef Robinson E, Chandarana H, Droxhinin L, et al. (2009) MRI features of HCC do not predict microvascular invasion in liver transplant for hepatocellular carcinoma. Liver Transpl 15:S111CrossRef
27.
Zurück zum Zitat Mendez-Sanchez N, Vasquez-Fernandez F, Zamora-Valdes D, Uribe M (2008) Sorafenib, a systemic therapy for hepatocellular carcinoma. Ann Hepatol 7(1):46–51PubMed Mendez-Sanchez N, Vasquez-Fernandez F, Zamora-Valdes D, Uribe M (2008) Sorafenib, a systemic therapy for hepatocellular carcinoma. Ann Hepatol 7(1):46–51PubMed
37.
Metadaten
Titel
Peritumoral tissue on preoperative imaging reveals microvascular invasion in hepatocellular carcinoma: a systematic review and meta-analysis
verfasst von
Hang-Tong Hu
Shun-Li Shen
Zhu Wang
Quan-Yuan Shan
Xiao-Wen Huang
Qiao Zheng
Xiao-Yan Xie
Ming-De Lu
Wei Wang
Ming Kuang
Publikationsdatum
30.05.2018
Verlag
Springer US
Erschienen in
Abdominal Radiology / Ausgabe 12/2018
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-018-1646-5

Weitere Artikel der Ausgabe 12/2018

Abdominal Radiology 12/2018 Zur Ausgabe

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

IT für Ärzte Nachrichten

Darauf haben viele Praxen gewartet: Das Zi hat eine Liste von Praxisverwaltungssystemen veröffentlicht, die von Nutzern positiv bewertet werden. Eine gute Grundlage für wechselwillige Ärzte und Psychotherapeuten.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

S3-Leitlinie zu Pankreaskrebs aktualisiert

23.04.2024 Pankreaskarzinom Nachrichten

Die Empfehlungen zur Therapie des Pankreaskarzinoms wurden um zwei Off-Label-Anwendungen erweitert. Und auch im Bereich der Früherkennung gibt es Aktualisierungen.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.